DNA X, Inc. 8-K/A

What Happened

• DNA X, Inc. (SONM) filed Amendment No. 1 to its Form 8‑K on March 2, 2026, reporting the completion of an acquisition or disposition of assets under Item 2.01. The amendment states it does not otherwise amend or update the original 8‑K and “speaks as of the date hereof.”
• The filing also includes Item 9.01 (financial statements and exhibits), indicating related exhibits were furnished with the amendment. The amendment does not disclose additional transactional terms in its brief text.

Key Details

• Filing date: March 2, 2026 (Amendment No. 1 to a prior 8‑K).
• Reported event: Completion of an acquisition or disposition of assets (Item 2.01).
• Amendment language: Does not modify other information in the original report and is effective as of the amendment date.
• Includes Item 9.01 — financial statements and exhibits were filed with the amendment.

Why It Matters

• A completed asset transaction can change DNA X’s business footprint, asset base, or future revenue potential; investors should review the original 8‑K and the exhibits included with this amendment for transaction terms and any disclosed financial effects.
• Because the amendment states it does not otherwise update the original report, investors should compare the original 8‑K, this amendment, and any subsequent filings to understand the full impact on the company’s finances and operations.